Fetal lower urinary tract obstruction

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:435365
Who is this for?
Show terms as
1FDA treatments1Active trials10Specialists8Treatment centers2Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Fetal lower urinary tract obstruction (LUTO) is a rare condition that develops before birth, when a blockage forms in the lower part of the baby's urinary tract — the area that includes the bladder, urethra, and nearby structures. This blockage prevents urine from flowing out of the body normally. Because a developing baby's kidneys produce most of the amniotic fluid surrounding them in the womb, a blocked urinary tract can cause the fluid levels to drop dangerously low — a condition called oligohydramnios. Without enough amniotic fluid, the baby's lungs may not develop properly, and the kidneys can become severely damaged. LUTO is also sometimes called bladder outlet obstruction or fetal obstructive uropathy. The most common cause in male fetuses is a condition called posterior urethral valves (PUV), where abnormal tissue flaps block the urethra. Other causes include urethral atresia (a completely closed urethra) and prune belly syndrome. The condition is much more common in male fetuses than female fetuses. Symptoms are detected before birth through ultrasound, which may show an enlarged bladder, swollen kidneys, and low amniotic fluid. Treatment options range from careful monitoring to fetal surgery aimed at relieving the blockage before birth. After birth, babies often need kidney care, bladder management, and sometimes kidney transplantation. Outcomes vary widely depending on how severe the blockage is and how early it is found and treated.

Also known as:

Key symptoms:

Enlarged or very full-looking bladder seen on prenatal ultrasoundSwollen or enlarged kidneys (hydronephrosis) before birthLow amniotic fluid levels around the baby (oligohydramnios)Underdeveloped lungs in the baby (pulmonary hypoplasia)Difficulty urinating or weak urine stream after birthKidney damage or kidney failure in infancy or childhoodRecurrent urinary tract infectionsBladder that does not empty properlyAbdominal swelling or distension in the newbornPoor growth and weight gain in infancyHigh blood pressure related to kidney problemsAbnormal appearance of the abdominal wall (in prune belly syndrome)

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

FDA & Trial Timeline

3 events
Sep 2023Rivfloza: FDA approved

to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, e.g., eGFR greater than or equal to 30 mL/min/1.73 m2

FDAcompleted
Oct 2018Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia

Mayo Clinic — PHASE1

TrialRECRUITING
Jan 2018Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction

Rodrigo Ruano — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Rivfloza

NEDOSIRAN· Novo NordiskOrphan Drug
to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, e.g., eGFR greater than or equal to 30

to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, e.g., eGFR greater than or equal to 30 mL/min/1.73 m2

Clinical Trials

1 recruitingView all trials with filters →
N/A1 trial
Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction
N/A
Actively Recruiting
PI: Rodrigo Ruano, MD, PhD. (University of Miami) · Sites: Miami, Florida; Rochester, Minnesota · Age: 1899 yrs

Specialists

10 foundView all specialists →
RP
Rodrigo Ruano, MD, PhD.
MIAMI, FL
Specialist
PI on 1 active trial
MM
Mauro Schenone, MD
ROCHESTER, MN
Specialist
PI on 4 active trials
MA
Meredith Atkinson
BALTIMORE, MD
Specialist
PI on 1 active trial
MP
Michael Belfort, MD PHD
HOUSTON, TX
Specialist
PI on 2 active trials
EJ
Eric Johnson
Specialist
2 Fetal lower urinary tract obstruction publications
AN
A A Nassr
HOUSTON, TX
Specialist
2 Fetal lower urinary tract obstruction publications
ED
Enrico Danzer
NEW YORK, NY
Specialist
2 Fetal lower urinary tract obstruction publications
AS
A A Shamshirsaz
HOUSTON, TX
Specialist
2 Fetal lower urinary tract obstruction publications
KS
Kunj R Sheth
FORT WORTH, TX
Specialist
2 Fetal lower urinary tract obstruction publications
YB
Yair J Blumenfeld
PALO ALTO, CA
Specialist
2 Fetal lower urinary tract obstruction publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

2 resources
Rivfloza(NEDOSIRAN)Novo Nordisk

REBETOL

Schering Corporation

REBETOL — Contact Schering Corporation

Unverified — confirm before calling
Patient Assistance
Manufacturer Program
Accepting applications

Travel Grants

No travel grants are currently matched to Fetal lower urinary tract obstruction.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Fetal lower urinary tract obstructionForum →

No community posts yet. Be the first to share your experience with Fetal lower urinary tract obstruction.

Start the conversation →

Latest news about Fetal lower urinary tract obstruction

Disease timeline:

New recruiting trial: Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia

A new clinical trial is recruiting patients for Fetal lower urinary tract obstruction

New recruiting trial: Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction

A new clinical trial is recruiting patients for Fetal lower urinary tract obstruction

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is my baby's blockage, and what does that mean for their kidneys and lungs?,Is my baby a candidate for fetal surgery or shunting, and what are the risks and benefits?,What should I expect in the first days and weeks after my baby is born?,How will we monitor my child's kidney function over time, and what signs of worsening should I watch for?,Will my child need to use a catheter, and how will we learn to manage that at home?,What is the likelihood that my child will need dialysis or a kidney transplant, and when might that happen?,Are there any genetic tests I should have done to understand why this happened and whether future pregnancies could be affected?

Common questions about Fetal lower urinary tract obstruction

What is Fetal lower urinary tract obstruction?

Fetal lower urinary tract obstruction (LUTO) is a rare condition that develops before birth, when a blockage forms in the lower part of the baby's urinary tract — the area that includes the bladder, urethra, and nearby structures. This blockage prevents urine from flowing out of the body normally. Because a developing baby's kidneys produce most of the amniotic fluid surrounding them in the womb, a blocked urinary tract can cause the fluid levels to drop dangerously low — a condition called oligohydramnios. Without enough amniotic fluid, the baby's lungs may not develop properly, and the kidne

At what age does Fetal lower urinary tract obstruction typically begin?

Typical onset of Fetal lower urinary tract obstruction is neonatal. Age of onset can vary across affected individuals.

Are there clinical trials for Fetal lower urinary tract obstruction?

Yes — 1 recruiting clinical trial is currently listed for Fetal lower urinary tract obstruction on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Fetal lower urinary tract obstruction?

10 specialists and care centers treating Fetal lower urinary tract obstruction are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Fetal lower urinary tract obstruction?

1 patient support program are currently tracked on UniteRare for Fetal lower urinary tract obstruction. See the treatments and support programs sections for copay assistance, eligibility, and contact details.